Vienna, Austria – 20 May 2021 – HeartBeat.bio AG, a biotech company focusing on cardiac drug discovery based on heart organoids, announced today the publication of “Cardioids reveal self-organizing principles of human cardiogenesis” in Cell, one of the highest impact, peer-reviewed scientific journals.Continue Reading

Vienna, Austria – 04 May 2021 – HeartBeat.bio AG, a spin-off company of the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), today announced that it has established its operations with seed financing of EUR 1.5 million from red-stars.com data AG. The Company is developing a high-throughput 3D screening platform for heart...Continue Reading